RegenETP, Inc.
Limited financial coverage for RGTPQ.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
RegenETP, Inc. , a biopharmaceutical firm in the clinical development phase, is headquartered in Salt Lake City, Utah. This company specializes in advancing and bringing to market a diverse array of regenerative tissue solutions and biological materials across the fields of medicine, biomedical engineering, and materials science within the United States.
- CEO
- Richard Hague
- IPO
- 1999
- Employees
- 42
- HQ
- Salt Lake City, UT, US
Get TickerSpark's AI analysis on RGTPQ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $0.22
- 52W Low
- $0.00
- 50D MA
- $0.15
- 200D MA
- $0.12
- Beta
- 2.91
- RSI (14)
- 54
- Avg Volume
- 3.13K
No earnings-call transcripts are available for RGTPQ yet.
- Free Float
- 94.3%
- Shares Outstanding
- 7.38M
- Float Shares
- 6.96M
Our RGTPQ coverage
Recent articles, reports, and earnings notes.
No research on RGTPQ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RGTPQ report →